与对免疫检查点抑制剂的初级耐药性相关的基因组和分子变化
Jyoti Malhotra1, Subhajyoti De2, Kim Nguyen3
1City of Hope National Medical Center, 1500 E. Duarte Road, Duarte, CA, 91010, USA. jymalhotra@coh.org.
Cancer immunology, immunotherapy : CII
|September 13, 2024
概括
了解瘤为什么会抵抗免疫检查点抑制剂是关键. 本综述探讨了原发性耐药性和治疗策略的分子机制,以提高免疫治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 对免疫检查点抑制剂 (ICI) 的临床反应在不同类型的瘤中存在显著差异.
- 许多瘤表现出对免疫疗法的原发性或获得性耐药性,需要对潜在机制有更深入的了解.
- 识别可靠的生物标志物对于优化治疗选择和测序至关重要,特别是在具有初级耐药性的瘤的第一线设置中.
研究的目的:
- 审查有关驱动对免疫疗法的原发性耐药性的分子机制的新兴数据.
- 探索克服免疫疗法耐药性的潜在治疗策略.
- 突出需要验证的预测模型来选择ICI治疗中的患者.
主要方法:
- 关于免疫疗法耐药性的当前研究的文献综述.
- 对原发性抗性的拟议生物机制的分析.
- 讨论潜在的治疗目标和策略.
主要成果:
- 已经提出了多种导致初级耐药性的分子机制,但需要未来的临床验证.
- 目前,单个生物标志物在预测ICI反应方面具有有限的特异性和敏感性.
- 需要综合预测模型来指导单疗法和组合疗法之间的决策.
结论:
- 了解原发性免疫疗法耐药性的分子基础对于开发有效的生物标志物和治疗策略至关重要.
- 需要进一步的研究和临床验证才能将拟议的机制转化为可操作的临床工具.
- 针对已识别的抗药性机制,有可能改善ICI治疗中患者的治疗结果.
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K